Madison Muller
Health Reporter at Bloomberg News
Health reporter for @business in New York | Email: [email protected] | Chicagoan at heart
Articles
-
2 weeks ago |
bloomberg.com | Madison Muller
NUTLEY, NJ - FEBRUARY 28: A researcher works in a lab that is developing testing for the COVID-19 coronavirus at Hackensack Meridian Health Center for Discovery and Innovation on February 28, 2020 in Nutley, New Jersey. The facility develops novel therapies for some of the world’s most difficult diseases. At least 53 countries have reported cases of infection.
-
3 weeks ago |
bloomberg.com | Madison Muller
The Hims app(Bloomberg) -- Hims & Hers Health Inc. said it’s buying privately held telehealth company Zava as it looks to expand its footprint in Europe. The deal will give the company access to Zava’s 1.3 million active users and bring its digital platform to patients in France, Germany and Ireland.
-
4 weeks ago |
bloomberg.com | Madison Muller
The Hims logo arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. A Super Bowl ad touting Hims & Hers Health Inc.'s copycat weight-loss drugs is getting pushback from the branded drugmakers' lobbying group, which says it's "misleading" and potentially violates marketing rules. Photographer: Gabby Jones/Bloomberg(Bloomberg) -- Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of popular weight-loss drugs.
-
4 weeks ago |
news.bloomberglaw.com | Madison Muller
Hims & Hers Health Inc. is cutting more than 4% of its workforce as it pivots away from selling cheap copycat versions of popular weight-loss drugs. The San Francisco-based telehealth company employs more than 1,600 staff. The moves will affect 68 people across various divisions, a spokesperson said. The company didn’t say which positions will be affected.
-
4 weeks ago |
wyomingnews.com | Madison Muller
State AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington D.C.West VirginiaWisconsinWyomingPuerto RicoUS Virgin IslandsArmed Forces AmericasArmed...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 5K
- Tweets
- 12K
- DMs Open
- Yes
RT @leilei_wuu: Lilly's top oncology execs: If a cancer program needs a mid-stage trial, its too mid for Lilly. My look at Lilly's cancer…
New: Hims is cutting more than 4% of its workforce. “While not easy, this step reflects our commitment to invest in the areas that will define our future,” a spokesperson told me. More here for @business⬇️ https://t.co/3Y8MEgYBiF
RT @gerryfsmith: US health officials are terminating a contract with Moderna worth up to $766 million to develop vaccines for bird flu. Sto…
